EUR 0.06
(-5.84%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2022 | 10.7 Million EUR | 455.82% |
2021 | 1.92 Million EUR | 19.18% |
2020 | 1.61 Million EUR | -55.48% |
2019 | 3.63 Million EUR | 49564.8% |
2018 | 7309.00 EUR | -8.1% |
2017 | 7953.00 EUR | 17.34% |
2016 | 6778.00 EUR | -3.2% |
2015 | 7002.00 EUR | 28.86% |
2014 | 5434.00 EUR | -99.83% |
2013 | 3.1 Million EUR | -4.02% |
2012 | 3.23 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 Q2 | - EUR | 0.0% |
2022 Q4 | 890 Thousand EUR | 0.0% |
2022 Q2 | 918 Thousand EUR | 0.0% |
2022 FY | 1.8 Million EUR | -6.13% |
2021 Q4 | 1.3 Million EUR | 0.0% |
2021 Q2 | 626 Thousand EUR | 0.0% |
2021 FY | 1.92 Million EUR | 19.18% |
2020 Q2 | 1.21 Million EUR | 0.0% |
2020 FY | 1.61 Million EUR | -55.48% |
2020 Q4 | 419 Thousand EUR | 0.0% |
2019 Q4 | 1.84 Million EUR | 0.0% |
2019 FY | 3.63 Million EUR | 49564.8% |
2019 Q2 | 1.79 Million EUR | 0.0% |
2018 Q2 | 3522.00 EUR | 0.0% |
2018 FY | 7309.00 EUR | -8.1% |
2018 Q4 | 3787.00 EUR | 0.0% |
2017 Q4 | 3904.00 EUR | 0.0% |
2017 FY | 7953.00 EUR | 17.34% |
2017 Q2 | 4049.00 EUR | 0.0% |
2016 Q4 | 2900.00 EUR | 0.0% |
2016 FY | 6778.00 EUR | -3.2% |
2016 Q2 | 3878.00 EUR | 0.0% |
2015 FY | 7002.00 EUR | 28.86% |
2015 Q2 | 3149.00 EUR | 0.0% |
2015 Q4 | 3853.00 EUR | 0.0% |
2014 FY | 5434.00 EUR | -99.83% |
2014 Q4 | 2650.00 EUR | 0.0% |
2014 Q2 | 2784.00 EUR | 0.0% |
2013 Q4 | 1576.00 EUR | -92.4% |
2013 FY | 3.1 Million EUR | -4.02% |
2013 Q3 | 20.75 Thousand EUR | 1146.25% |
2013 Q2 | 1665.00 EUR | -91.98% |
2013 Q1 | 20.75 Thousand EUR | 0.0% |
2012 FY | 3.23 Million EUR | 0.0% |
2012 Q1 | 25.25 Thousand EUR | 0.0% |
2012 Q2 | 25.25 Thousand EUR | 0.0% |
2012 Q3 | 25.25 Thousand EUR | 0.0% |
2012 Q4 | 20.75 Thousand EUR | -17.82% |
2011 Q4 | 25.25 Thousand EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Crossject Société Anonyme | 5.66 Million EUR | -88.967% |
Spineway SA | 6.06 Million EUR | -76.417% |
Amplitude Surgical SA | 23.96 Million EUR | 55.327% |
Sartorius Stedim Biotech S.A. | 749 Million EUR | 98.571% |
EssilorLuxottica Société anonyme | 12.65 Billion EUR | 99.915% |
bonyf N.V. | 66.3 Thousand EUR | -16044.357% |